DK1027359T3 - Monocykliske L-nukleosider, analoger og anvendelser deraf - Google Patents

Monocykliske L-nukleosider, analoger og anvendelser deraf

Info

Publication number
DK1027359T3
DK1027359T3 DK97912762T DK97912762T DK1027359T3 DK 1027359 T3 DK1027359 T3 DK 1027359T3 DK 97912762 T DK97912762 T DK 97912762T DK 97912762 T DK97912762 T DK 97912762T DK 1027359 T3 DK1027359 T3 DK 1027359T3
Authority
DK
Denmark
Prior art keywords
monocyclic
compounds
useful
nucleosides
analogs
Prior art date
Application number
DK97912762T
Other languages
Danish (da)
English (en)
Inventor
Robert Tam
Devron Averett
Kandasamy Ramasamy
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Application granted granted Critical
Publication of DK1027359T3 publication Critical patent/DK1027359T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
DK97912762T 1996-10-16 1997-10-15 Monocykliske L-nukleosider, analoger og anvendelser deraf DK1027359T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2858596P 1996-10-16 1996-10-16
PCT/US1997/018767 WO1998016186A2 (en) 1996-10-16 1997-10-15 Monocyclic l-nucleosides, analogs and uses thereof

Publications (1)

Publication Number Publication Date
DK1027359T3 true DK1027359T3 (da) 2003-08-11

Family

ID=21844262

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01108303T DK1132393T3 (da) 1996-10-16 1997-10-15 L-Ribavirin og anvendelser heraf
DK97912762T DK1027359T3 (da) 1996-10-16 1997-10-15 Monocykliske L-nukleosider, analoger og anvendelser deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01108303T DK1132393T3 (da) 1996-10-16 1997-10-15 L-Ribavirin og anvendelser heraf

Country Status (26)

Country Link
US (4) US6130326A (de)
EP (1) EP1027359B9 (de)
JP (2) JP2002503212A (de)
KR (1) KR100398923B1 (de)
CN (1) CN1268140A (de)
AT (2) ATE236921T1 (de)
AU (1) AU738170B2 (de)
BR (1) BR9712527A (de)
CA (1) CA2267279A1 (de)
CZ (1) CZ120699A3 (de)
DE (2) DE69721339T2 (de)
DK (2) DK1132393T3 (de)
ES (2) ES2195970T3 (de)
HK (2) HK1028977A1 (de)
HU (1) HUP0001107A3 (de)
IL (1) IL129126A0 (de)
NO (1) NO313417B1 (de)
NZ (1) NZ334915A (de)
PL (1) PL187107B1 (de)
PT (2) PT1132393E (de)
RU (2) RU2188828C2 (de)
SI (1) SI20076A (de)
SK (1) SK284054B6 (de)
UA (1) UA63915C2 (de)
WO (1) WO1998016186A2 (de)
YU (1) YU18799A (de)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016186A2 (en) * 1996-10-16 1998-04-23 Icn Pharmaceuticals, Inc. Monocyclic l-nucleosides, analogs and uses thereof
JP2002501546A (ja) * 1997-06-30 2002-01-15 アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド チアゾフリンおよびその他のｃ−ヌクレオシドを作製する方法
JP4596495B2 (ja) * 1997-07-18 2010-12-08 ソニー株式会社 制御装置、制御方法、電気機器システム、電気機器システムの制御方法、および、記録媒体
US7901400B2 (en) 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
CA2348948C (en) * 1998-11-05 2007-09-18 Gilles Gosselin .beta.-l-2'-deoxy-nucleosides for the treatment of hiv infection
KR100618028B1 (ko) 1998-11-05 2006-08-30 쌍트르 나쉬오날 드 라 르쉐르스 쉬앙티피끄 항-ｂ형 간염 활성을 가진 뉴클레오시드
US6407077B1 (en) 1998-11-05 2002-06-18 Emory University β-L nucleosides for the treatment of HIV infection
HUP0200027A2 (en) * 1999-01-29 2002-04-29 Icn Pharmaceuticals Modulation of immune response by ribavirin
US7084125B2 (en) 1999-03-18 2006-08-01 Exiqon A/S Xylo-LNA analogues
CN102180924A (zh) 1999-05-04 2011-09-14 桑塔里斯制药公司 L-核糖-lna类似物
US6525191B1 (en) * 1999-05-11 2003-02-25 Kanda S. Ramasamy Conformationally constrained L-nucleosides
CA2382324A1 (en) * 1999-08-31 2001-03-08 Amersham Plc Nucleoside analogues
US6664399B1 (en) * 1999-09-02 2003-12-16 E. I. Du Pont De Nemours & Company Triazole linked carbohydrates
US6518253B1 (en) * 1999-11-19 2003-02-11 Robert Tam Treatment of viral infections using the L-isomer of ribavirin
CN1420723A (zh) * 1999-12-23 2003-05-28 Icn药品公司 L－核苷、l－核苷酸及其类似物的组合物和方法
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US6495677B1 (en) 2000-02-15 2002-12-17 Kanda S. Ramasamy Nucleoside compounds
US6455508B1 (en) * 2000-02-15 2002-09-24 Kanda S. Ramasamy Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
JP2003532643A (ja) * 2000-04-13 2003-11-05 フアーマセツト・リミテツド 肝炎ウイルス感染症を治療するための３’−または２’−ヒドロキシメチル置換ヌクレオシド誘導体
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
OA12382A (en) * 2000-05-26 2006-04-17 Novirio Pharmaceuticals Ltd Methods and compositions for treating flavivirusesand pestiviruses.
US6815542B2 (en) * 2000-06-16 2004-11-09 Ribapharm, Inc. Nucleoside compounds and uses thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6960569B2 (en) 2000-08-17 2005-11-01 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
ES2208540T3 (es) * 2001-07-30 2004-06-16 Clariant Life Science Molecules (Italia) Spa Procedimiento para la preparacion de ribavirina.
WO2003026589A2 (en) * 2001-09-28 2003-04-03 Idenix (Cayman) Limited Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
BR0213861A (pt) * 2001-11-02 2004-12-21 Sandoz Ag Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida
KR100411398B1 (ko) * 2001-12-06 2003-12-18 주식회사유한양행 베타-디-리보푸라노즈 유도체의 제조방법
WO2003073989A2 (en) * 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
AU2003265331B2 (en) 2002-05-06 2008-03-20 Covidien Ag Blood detector for controlling anesu and method therefor
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US7608600B2 (en) * 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) * 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
BR0312278A (pt) * 2002-06-28 2007-06-19 Idenix Cayman Ltd éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
EP1545545A4 (de) * 2002-08-01 2008-09-03 Pharmasset Inc VERBINDUNGEN MIT DEM BICYCLO 4.2.1 NONAN-SYSTEM ZUR BEHANDLUNG VON i FLAVIVIRIDAE /i INFEKTIONEN
JP2005539032A (ja) * 2002-08-12 2005-12-22 エフ．ホフマン−ラ　ロシュ　アーゲー リボフラノースの製造方法
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
KR20050089799A (ko) 2002-10-29 2005-09-08 콜리 파마슈티칼 그룹, 리미티드 Ｃ형 간염 바이러스 감염의 치료에 있어 ＣｐＧ올리고뉴클레오티드의 용도
BR0316363A (pt) * 2002-11-15 2005-10-04 Idenix Cayman Ltd Nucleosìdeos 2'-ramificado e mutação de flaviviridae
US7044948B2 (en) 2002-12-10 2006-05-16 Sherwood Services Ag Circuit for controlling arc energy from an electrosurgical generator
MXPA05006230A (es) * 2002-12-12 2005-09-20 Idenix Cayman Ltd Proceso para la produccion de nucleosidos ramificados-2'.
WO2004058792A1 (en) * 2002-12-23 2004-07-15 Idenix (Cayman) Limited Process for the production of 3'-nucleoside prodrugs
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
AU2004224575A1 (en) * 2003-03-28 2004-10-07 Pharmasset Ltd. Compounds for the treatment of flaviviridae infections
EP1617776B1 (de) 2003-05-01 2015-09-02 Covidien AG System zur programmierung und kontrolle eines elektrochirurgischen generatorsystems
BRPI0410846B8 (pt) 2003-05-30 2021-05-25 Gilead Pharmasset Llc nucleosídeo e composição farmacêutica compreendendo o mesmo
US20050009848A1 (en) * 2003-07-10 2005-01-13 Icn Pharmaceuticals Switzerland Ltd. Use of antivirals against inflammatory bowel diseases
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
DE602004028841D1 (de) * 2003-07-25 2010-10-07 Centre Nat Rech Scient Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
WO2005018330A1 (en) * 2003-08-18 2005-03-03 Pharmasset, Inc. Dosing regimen for flaviviridae therapy
US8104956B2 (en) 2003-10-23 2012-01-31 Covidien Ag Thermocouple measurement circuit
EP1675499B1 (de) 2003-10-23 2011-10-19 Covidien AG Redundante temperaturüberwachung für elektrochirurgische systeme zur sicherheitserhöhung
US7396336B2 (en) 2003-10-30 2008-07-08 Sherwood Services Ag Switched resonant ultrasonic power amplifier system
US7131860B2 (en) 2003-11-20 2006-11-07 Sherwood Services Ag Connector systems for electrosurgical generator
US7766905B2 (en) 2004-02-12 2010-08-03 Covidien Ag Method and system for continuity testing of medical electrodes
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
US7780662B2 (en) 2004-03-02 2010-08-24 Covidien Ag Vessel sealing system using capacitive RF dielectric heating
WO2006000922A2 (en) * 2004-06-23 2006-01-05 Idenix (Cayman) Limited 5-aza-7-deazapurine derivatives for treating infections with flaviviridae
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
RU2433124C2 (ru) 2004-09-14 2011-11-10 Фармассет, Инк. Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
US7687473B2 (en) * 2005-01-07 2010-03-30 Health Research, Inc. 5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
WO2006105440A2 (en) * 2005-03-30 2006-10-05 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
US7968697B2 (en) * 2005-05-25 2011-06-28 Chrontech Pharma Ab Hepatitis C virus non-structural NS3/4A fusion gene
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
EP1976382B1 (de) * 2005-12-23 2013-04-24 IDENIX Pharmaceuticals, Inc. Verfahren zur herstellung eines synthetischen zwischenprodukts für die herstellung von verzweigten nukleosiden
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
KR20080105048A (ko) * 2006-03-09 2008-12-03 옴 파르마 면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료
FR2907786B1 (fr) * 2006-10-27 2009-09-18 Univ Grenoble 1 Thionucleosides et applications pharmaceutiques
AU2007325551A1 (en) * 2006-09-11 2008-06-05 Arrowhead Center Inc. Azole nucleosides and use as inhibitors of RNA and DNA varial polymerases
US8394935B2 (en) * 2006-12-08 2013-03-12 Api Corporation Method for producing furanose derivative
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
EP2185195A2 (de) * 2007-08-16 2010-05-19 Tripep Ab Immunogen-plattform
EP3025714B9 (de) 2007-09-14 2020-11-18 Biogen MA Inc. Zusammensetzungen und verfahren zur behandlung von progressiver multifokaler leukoenzephalopathie (pml)
US8227431B2 (en) 2008-03-17 2012-07-24 Hetero Drugs Limited Nucleoside derivatives
WO2009130588A2 (en) * 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
SG193206A1 (en) 2008-05-15 2013-09-30 Celgene Corp Oral formulations of cytidine analogs and methods of use thereof
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG194404A1 (en) 2008-12-23 2013-11-29 Gilead Pharmasset Llc Synthesis of purine nucleosides
WO2010075549A2 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside phosphoramidates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
AP2011005929A0 (en) * 2009-03-20 2011-10-31 Alios Biopharma Inc Substituted nucleoside and nucleotide analogs.
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
BR112012024884A2 (pt) 2010-03-31 2016-10-18 Gilead Pharmasset Llc síntese estereosseletiva de ativos contendo fósforo
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
PE20140608A1 (es) 2010-09-22 2014-06-12 Alios Biopharma Inc Analogos de nucleotidos sustituidos
US8877731B2 (en) 2010-09-22 2014-11-04 Alios Biopharma, Inc. Azido nucleosides and nucleotide analogs
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
GB201021867D0 (en) * 2010-12-23 2011-02-02 Mologen Ag Non-coding immunomodulatory DNA construct
CN102153548B (zh) * 2011-02-24 2012-11-28 河北大学 一种含有噻唑（嗪）烷酮环的类核苷衍生物及其制备方法和其在药物制剂中的应用
US9951098B2 (en) * 2011-03-31 2018-04-24 Pharmion Llc Synthesis of 5-azacytidine
CN103945902B (zh) 2011-08-30 2018-07-20 阿斯泰克斯制药公司 地西他滨衍生物制剂
AU2012308295B2 (en) 2011-09-16 2017-10-26 Gilead Pharmasset Llc Methods for treating HCV
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CA3107640A1 (en) 2011-12-22 2013-06-27 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof and their use in ameliorating or treating a disease or condition associated with viral infections
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
NZ631601A (en) 2012-03-21 2016-06-24 Alios Biopharma Inc Solid forms of a thiophosphoramidate nucleotide prodrug
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
CN104395330B (zh) 2012-05-25 2018-03-13 爱尔兰詹森科学公司 尿嘧啶基螺氧杂环丁烷核苷
US9243022B2 (en) 2012-12-21 2016-01-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
LT2950786T (lt) 2013-01-31 2020-03-10 Gilead Pharmasset Llc Dviejų antivirusinių junginių preparatų kompozicija
EP2984098A2 (de) 2013-04-12 2016-02-17 Achillion Pharmaceuticals, Inc. Deuterierte nukleosid-prodrugs zur behandlung von hcv
ES2792503T3 (es) 2013-08-27 2020-11-11 Gilead Pharmasset Llc Formulación combinada de dos compuestos antivirales
US9862743B2 (en) 2013-10-11 2018-01-09 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CN106102771B (zh) 2014-01-07 2021-06-29 巴比塔·阿格拉沃尔 免疫调节组合物及其使用方法
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
RU2016149767A (ru) 2014-06-06 2018-07-16 Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед Аналоги никотинамидрибозида и фармацевтические композиции и их применение
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
US10273305B2 (en) 2015-04-02 2019-04-30 Ablynx N.V. Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
CA2991167A1 (en) 2015-07-02 2017-01-05 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
WO2017218580A1 (en) 2016-06-14 2017-12-21 Rejuvenation Therapeutics Corporation Synthetic methods for the preparation of nicotinamide riboside and related compounds
US10202412B2 (en) 2016-07-08 2019-02-12 Atea Pharmaceuticals, Inc. β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
RU2624018C2 (ru) * 2016-09-26 2017-06-30 Федеральное государственное бюджетное учреждение науки Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН (ИБХ РАН) Амид 5-(тетрагидрофуран-2-ил)-1,2,4-триазол-3-карбоновой кислоты, обладающий противовирусной активностью, и способ его получения
MX2020001233A (es) 2017-08-03 2020-07-20 Otsuka Pharma Co Ltd Compuesto farmaceutico y metodos de purificacion del mismo.
US11970482B2 (en) 2018-01-09 2024-04-30 Ligand Pharmaceuticals Inc. Acetal compounds and therapeutic uses thereof
MX2021009278A (es) * 2019-02-01 2021-08-24 Janssen Biopharma Inc Nucleosidos antivirales y derivados de estos.
JOP20220130A1 (ar) 2019-12-06 2023-01-30 Vertex Pharma مجموعات تترا هيدروفيوران بها استبدال في صورة عوامل تعديل لقنوات الصوديوم
UY39800A (es) 2021-06-04 2023-01-31 Vertex Pharma N–(hidroxialquil (hetero)aril) tetrahidrofuran carboxamidas como moduladores de canales de sodio
WO2023288047A2 (en) * 2021-07-15 2023-01-19 Alnylam Pharmaceuticals, Inc. Multiplexing targeting ligands through click chemistry at the anomeric site of sugars

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948885A (en) * 1973-03-19 1976-04-06 Icn Pharmaceuticals, Inc. 5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside
US4138547A (en) * 1977-12-22 1979-02-06 Icn Pharmaceuticals, Inc. Process for preparing 1,2,4-triazole nucleosides
DK553781A (da) * 1980-12-15 1982-06-16 Vira Tek Inc Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosulthiazol-4-carboxid-estere
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
CA1317588C (en) * 1988-02-29 1993-05-11 Tohru Ueda Imidazole derivatives, process for production thereof, and use thereof
US5082829A (en) * 1989-01-24 1992-01-21 Gensia Pharmaceuticals AICA riboside prodrugs
US4992426A (en) * 1989-02-27 1991-02-12 Nucleic Acid Research Institute Antiparasitic 5'-sulfamoyl nucleosides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5248776A (en) * 1990-12-05 1993-09-28 University Of Georgia Research Foundation, Inc. Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
US5438131A (en) * 1992-09-16 1995-08-01 Bergstrom; Donald E. 3-nitropyrrole nucleoside
WO1994021658A1 (en) * 1993-03-15 1994-09-29 Kalman Thomas I Antiviral imidazolinone nucleoside derivatives
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
US5567689A (en) * 1993-08-13 1996-10-22 The Uab Research Foundation Methods for increasing uridine levels with L-nucleosides
US5599796A (en) * 1993-12-02 1997-02-04 Emory University Treatment of urogenital cancer with boron neutron capture therapy
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
DE19518216A1 (de) * 1994-10-07 1996-04-11 Max Delbrueck Centrum Neue ß-L-Nucleoside und ihre Verwendung
US5672594A (en) * 1994-10-24 1997-09-30 Genencor International, Inc. L-erythrosyl nucleosides
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
IT1281498B1 (it) * 1995-06-07 1998-02-18 Sardinian Antiviral Research C Pirazolo - derivati ad attivita' antitumorale, processo per la loro preparazione e composizioni farmaceutiche che li contengono , e
WO1998016186A2 (en) * 1996-10-16 1998-04-23 Icn Pharmaceuticals, Inc. Monocyclic l-nucleosides, analogs and uses thereof

Also Published As

Publication number Publication date
US6552183B1 (en) 2003-04-22
AU4986797A (en) 1998-05-11
RU2188828C2 (ru) 2002-09-10
BR9712527A (pt) 2000-03-08
KR100398923B1 (ko) 2003-09-19
US6573248B2 (en) 2003-06-03
NO313417B1 (no) 2002-09-30
AU738170B2 (en) 2001-09-13
CA2267279A1 (en) 1998-04-23
SK284054B6 (sk) 2004-08-03
US20020095033A1 (en) 2002-07-18
CN1268140A (zh) 2000-09-27
DE69721339T2 (de) 2004-01-22
UA63915C2 (uk) 2004-02-16
HUP0001107A3 (en) 2003-01-28
EP1027359B1 (de) 2003-04-23
HK1028977A1 (en) 2001-03-16
IL129126A0 (en) 2000-02-17
US6130326A (en) 2000-10-10
US20030018186A1 (en) 2003-01-23
PL333419A1 (en) 1999-12-06
KR20000049224A (ko) 2000-07-25
CZ120699A3 (cs) 1999-09-15
EP1027359A2 (de) 2000-08-16
ATE236921T1 (de) 2003-04-15
NO991785D0 (no) 1999-04-15
DE69721339D1 (de) 2003-05-28
JP2003176296A (ja) 2003-06-24
SK47199A3 (en) 2000-12-11
WO1998016186A2 (en) 1998-04-23
HK1038365A1 (en) 2002-03-15
US6642206B2 (en) 2003-11-04
PT1027359E (pt) 2003-09-30
PL187107B1 (pl) 2004-05-31
ATE238328T1 (de) 2003-05-15
PT1132393E (pt) 2003-08-29
EP1027359A4 (de) 2001-07-25
DE69720811T2 (de) 2004-03-11
EP1027359B9 (de) 2003-09-17
ES2195970T3 (es) 2003-12-16
NZ334915A (en) 2000-11-24
HUP0001107A2 (hu) 2001-06-28
WO1998016186A3 (en) 1998-06-11
DE69720811D1 (de) 2003-05-15
JP2002503212A (ja) 2002-01-29
DK1132393T3 (da) 2003-07-21
ES2195125T3 (es) 2003-12-01
SI20076A (sl) 2000-04-30
NO991785L (no) 1999-06-15
YU18799A (sh) 2002-06-19
RU2001132536A (ru) 2003-08-20

Similar Documents

Publication Publication Date Title
DK1027359T3 (da) Monocykliske L-nukleosider, analoger og anvendelser deraf
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
DE68909219D1 (de) Behandlung von obesitas.
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DE68907423D1 (de) Behandlung der akne.
DK90089A (da) Hudbehandlingspraeparat
ITTO910156A0 (it) Composto e metodo per esaltare le prestazione umane.
IT8721271A0 (it) Pressa per balle di grandi dimensioni.
DE3772513D1 (de) Behandlung von gewebe zur verbesserung seiner anfaerbbarkeit.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
DE3882611D1 (de) Menschliches interleukin-4, expressionsvektoren dafuer und diese enthaltende transformanten.
IT8448001A1 (it) Forme galeniche di sulpiride utilizzabili per via orale e procedimento per produrle.
DE59809344D1 (de) Disubstituierte biphenyloxazoline
ATE117318T1 (de) Aus blaualgen hergestellte biologisch aktive verbindungen.
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
IT1238681B (it) Composto antibiotico,jantinomicina e procedimento per prepararlo
ATE215935T1 (de) Heterozyklische verbidungen mit mmp und tnf inhibitorisher wirkung
FI873923A0 (fi) Realiseringsmekanism pao bitnivao foer en syntesprocedur vid kretsplanering.
BR6801156U (pt) Mesa de praia,lago,lagoa,rio
IT218809Z2 (it) . pannello ortopedico anatomico per riposare, dormire e curare
NO881342L (no) Kosmetisk hudbehandling.
IT8630843V0 (it) Divano letto anatomico balestra.
IT1230963B (it) Pozzolane artificiali e procedimento per produrle.
MX9709982A (es) Retinoides de chalcona y uso de los mismos.
IT8903671A0 (it) Apparecchiatura per effettuare trattamenti estetici.